Reyoung Company Profile
✉ Email this page to a colleague
What is the competitive landscape for REYOUNG, and what generic and branded alternatives to REYOUNG drugs are available?
REYOUNG has five approved drugs.
Summary for Reyoung
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Reyoung
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reyoung | TENOFOVIR DISOPROXIL FUMARATE | tenofovir disoproxil fumarate | TABLET;ORAL | 211337-001 | Mar 2, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Reyoung | SERTRALINE HYDROCHLORIDE | sertraline hydrochloride | TABLET;ORAL | 078677-002 | Mar 4, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Reyoung | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 208494-001 | Jun 12, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Reyoung | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 208494-003 | Jun 12, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Reyoung | SERTRALINE HYDROCHLORIDE | sertraline hydrochloride | TABLET;ORAL | 078677-001 | Mar 4, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Reyoung | FENOFIBRATE (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 207805-002 | Nov 16, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
